These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 16227418

  • 1. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder.
    Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, Tanaka F, Kamachi M, Aratake K, Nakamura H, Ida H, Uetani M, Kawakami A, Eguchi K.
    Ann Rheum Dis; 2005 Nov; 64(11):1653-5. PubMed ID: 16227418
    [Abstract] [Full Text] [Related]

  • 2. RS3PE syndrome developing during the course of probable toxic shock syndrome: a case report.
    Kyotani M, Kenzaka T, Nishio R, Akita H.
    BMC Infect Dis; 2018 Apr 13; 18(1):174. PubMed ID: 29653519
    [Abstract] [Full Text] [Related]

  • 3. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis?
    Sibilia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, Kuntz JL.
    J Rheumatol; 1999 Jan 13; 26(1):115-20. PubMed ID: 9918251
    [Abstract] [Full Text] [Related]

  • 4. [Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome)].
    Yamanishi Y, Taooka Y, Mukuzono H, Aoi K, Ishibe Y, Yamana S.
    Ryumachi; 1993 Apr 13; 33(2):162-8. PubMed ID: 8316907
    [Abstract] [Full Text] [Related]

  • 5. Remitting seronegative symmetrical synovitis with pitting edema syndrome: followup for neoplasia.
    Russell EB.
    J Rheumatol; 2005 Sep 13; 32(9):1760-1. PubMed ID: 16142875
    [Abstract] [Full Text] [Related]

  • 6. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome) showing dermatomyositis-like eruption.
    Takeda K, Fujita J, Fujii T, Tanabe H, Mochizuki T, Yanagihara M.
    J Dermatol; 2010 Jan 13; 37(1):102-6. PubMed ID: 20175831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.
    Yanamoto S, Fukae J, Fukiyama Y, Fujioka S, Ouma S, Tsuboi Y.
    J Med Case Rep; 2016 Jul 20; 10():198. PubMed ID: 27439425
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Remitting Seronegative Symmetrical Synovitis with Pitting Oedema (RS3PE) Syndrome in a Chronic Kidney Disease Patient Undzergoing Haemodialysis.
    Shindo M, Ishii H, Kitano T, Miyazawa H, Ito K, Ueda Y, Hirai K, Kaku Y, Hoshino T, Mori H, Ookawara S, Morishita Y.
    Nephrology (Carlton); 2016 Dec 20; 21(12):1073. PubMed ID: 27870229
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring of therapeutic efficacy in a patient with RS₃PE syndrome by serologic variables and radiographic methods.
    Kawashiri SY, Nakano M, Kawakami A, Eguchi K.
    Rheumatol Int; 2010 Nov 20; 30(12):1677-80. PubMed ID: 19809820
    [Abstract] [Full Text] [Related]

  • 13. Parvovirus B19: another agent associated with remitting seronegative symmetrical synovitis with pitting edema.
    Perandones CE, Colmegna I, Arana RM.
    J Rheumatol; 2005 Feb 20; 32(2):389-90. PubMed ID: 15693107
    [Abstract] [Full Text] [Related]

  • 14. Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.
    Cinelli M, Guiducci S, Del Rosso A, Pignone A, Del Rosso M, Fibbi G, Serratì S, Gabrielli A, Giacomelli R, Piccardi N, Matucci Cerinic M.
    Scand J Rheumatol; 2006 Feb 20; 35(5):346-50. PubMed ID: 17062432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of leptin, interleukin-1beta, tumor necrosis factor-alpha and vascular endothelial growth factor in serum and follicular fluids of women undergoing controlled ovarian hyperstimulation as prognostic markers of ICSI outcome.
    Nikolettos N, Asimakopoulos B, Nicolettos N, Efthimiadou A, Mourvati E, Demirel C.
    In Vivo; 2004 Feb 20; 18(5):667-73. PubMed ID: 15523910
    [Abstract] [Full Text] [Related]

  • 17. [RS3PE syndrome: presentation of two cases].
    Parra Ródenas JV, Calvo Catalá J, González-Cruz Cervellera MI, Cervera Moscardó J, Valero Prieto I.
    An Med Interna; 1996 Dec 20; 13(12):601-2. PubMed ID: 9063938
    [Abstract] [Full Text] [Related]

  • 18. RS3PE syndrome: no evidence for retroviruses.
    Russell EB, McCarty DJ, Schwab J, Hanel D, Komorowski R, Stransky G, Gay S.
    J Rheumatol; 1994 Jun 20; 21(6):1105-6. PubMed ID: 7932422
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM, El-Kerdany TH.
    Pediatr Allergy Immunol; 2007 Jun 20; 18(4):346-53. PubMed ID: 17346298
    [Abstract] [Full Text] [Related]

  • 20. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study.
    Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, Padula A, Pavlica P, Boiardi L.
    Ann Rheum Dis; 1999 Apr 20; 58(4):230-6. PubMed ID: 10364902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.